Contract Pharma

Breaking News | Drug Development | Industry News

Bristol Myers Squibb Expands at Cambridge Crossing

Adds remaining 113,000 square feet to its initial lease at 250 Water Street.

Kristin Brooks 04.16.21

Breaking News | Drug Development | Industry News

Amgen Completes Five Prime Acquisition

Gains pipeline of immuno-oncology and targeted cancer therapies, including a Phase 3 trial-ready, first-in-class program for gastric cancer.

Kristin Brooks 04.16.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Sartorius Expands in the UK

New 58,000-square-foot facility aims to simplify and accelerate the production of downstream processing equipment.

Kristin Brooks 04.16.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Abenza Chooses North Carolina for New Biologics Manufacturing Site

GMP manufacturing will commence in mid-2022.

Charles Sternberg, Assistant Editor 04.15.21

Breaking News | Industry News | Information Technology

Arkema Recruits Dotmatics as its R&D Digitalization Partner

Agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products.

Charles Sternberg, Assistant Editor 04.15.21

Breaking News | Drug Development | Industry News

BioVersys Gets EIB Funds to Address Antimicrobial Resistance

Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumannii

Kristin Brooks 04.14.21

Breaking News | Industry News | Microbiology

Microbiologics Expands Virology Services

Increases capabilities and capacity to provide anti-infective testing, assay development and biomaterial production services for highly infectious pathogens.

Kristin Brooks 04.14.21

Biologics, Proteins, Vaccines | Breaking News | Industry News | Information Technology

ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies

Aims to provide improved product tracking, scheduling and live monitoring of the manufacturing status across the entire CGT supply chain from vein to vein.

Kristin Brooks 04.14.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Albumedix Completes Commercial-Scale Mfg. Facility Expansion

Will service increasing demand for products and technologies for cell and gene therapies, vaccines, diagnostics, protein and peptide therapeutics.

Kristin Brooks 04.14.21

APIs | Drug Development | Process Validation

Exploring ICP-MS expertise at Almac

A discussion about Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and its importance within drug development.

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Catalent Biologics Completes Madison Expansion

More than doubles overall CGMP-scale capacity increasing the number of manufacturing suites at the site to five.

Kristin Brooks 04.13.21

Breaking News | Industry News | Microbiology

Lonza Expands PyroTec PRO for Endotoxin Testing

Aims to enable users to streamline and improve the performance of the QC laboratory, increasing lab efficiency and productivity.

Kristin Brooks 04.12.21

Breaking News | Clinical Trials | Drug Development | Trials & Filings

FDA Accepts Airway Therapeutics’ IND for COVID Treatment

To initiate a Phase 1b trial to confirm the feasibility of intratracheal administrations of AT-100 and its beneficial safety and tolerability profile.

Kristin Brooks 04.12.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Sanofi Invests in Cutting Edge Vax Production Site in Singapore

The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.

Kristin Brooks 04.12.21

R&D

Digitalization and the Future of Formulating in Modern R&D Labs

This webinar will focus on the benefits of implementing a true data infrastructure, and the challenges that organizations will face along this journey.

04.12.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Sanofi Acquires Tidal Therapeutics

Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.

Kristin Brooks 04.12.21

Breaking News | Clinical Trials | CRO News | Industry News

Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

Offers full-service human absorption, metabolism, and excretion (hAME) studies with radiolabeled compounds.

Tim Wright, Editor, Contract Pharma 04.09.21

Analytical Services | Breaking News | Clinical Trial Materials | Drug Development | Industry News

Ascendia Pharmaceuticals Poised for Expansion

CDMO secures growth equity investment from Signet Healthcare Partners.

Tim Wright, Editor, Contract Pharma 04.09.21

Breaking News | Clinical Trials | CRO News

Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

Adding layer of technology to HGH treatments aims to facilitate better patient compliance.

Kristin Brooks 04.08.21

Analytical Services | Bioanalytical Services | Breaking News | Industry News

Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.

Kristin Brooks 04.08.21

Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News

Alkermes, Merck Enter Clinical Trial and Supply Agreement

To evaluate nemvaleukin alfa in combination with Keytruda in patients with platinum-resistant ovarian cancer.

Tim Wright, Editor, Contract Pharma 04.07.21

Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.

Tim Wright, Editor, Contract Pharma 04.07.21

Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News

Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate

Work together to develop and commercialize CHI’s novel dry-powder inhaler product.

Charles Sternberg, Assistant Editor 04.07.21

Breaking News | Clinical Trials | Drug Development | Industry News

Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment

To support the testing of SPI-1005 in two Phase 2 clinical trials for the treatment of COVID-19.

Kristin Brooks 04.06.21

Breaking News | Clinical Trials | CRO News | Drug Development

Moleculin Selects IQVIA Biotech to Advance COVID Treatment

IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.

Kristin Brooks 04.06.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Industry News

Moderna, Catalent Enter Long-Term Strategic Vax Pact

Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.

Kristin Brooks 04.06.21

Sanofi to Build New $700M Flu Vaccine Facility in Canada

Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.

Tim Wright, Editor, Contract Pharma 04.05.21

Breaking News | Industry News | Information Technology

LabVantage Solutions Expands and Improves its Portfolio

Unveils two new solutions and an updated version of its flagship LIMS platform.

Charles Sternberg, Assistant Editor 04.05.21

Bioanalytical Services | Breaking News | CRO News | Industry News

Charles River Acquires Retrogenix

Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.

Tim Wright, Editor, Contract Pharma 04.05.21

Biologics, Proteins, Vaccines | Regulatory Affairs

What Will Change at FDA for 2021?

(R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?

Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21

Drug Delivery

The Ever-Evolving World of Combination Products

Looking at the benefits and challenges of the trend towards combination products.

Ricki A. Chase, M.S, Lachman Consultants 04.01.21

Clinical Trials | Drug Development | QA/QC

RBQM Comes of Age: COVID as a Catalyst for Change

Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.

Online Exclusives Kristin Brooks, Managing Editor 04.01.21

R&D

Small Innovators & Niche CROs

Smaller CROs have the opportunity to provide a niche approach to its clients, particularly smaller sponsors who have shared synergies.

Neil Goodman, David Bruce and Mohamed El Malt, Europital 04.01.21

Laboratory Testing

Focus on Science

How to maximize lab performance and value through comprehensive equipment management.

Rohit Shroff, Senior Vice President, Global Lab Products, Avantor 04.01.21

Analytical Services | Bioanalytical Services | Laboratory Testing | R&D

Rapid and Data Rich Chromatographic Method Development

An overview of what to consider when developing chromatographic methods.

Daniel Kirschner, Executive Director of Analytical Services, Cambrex - Durham, North Carolina 04.01.21

Laboratory Testing | R&D

How Modern Near-Infrared Came to Be

First region outside the visible to be discovered and last to be utilized.

Gary E. Ritchie, Contributing Writer 04.01.21

Breaking News | Drug Development

Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio

Expands its oncology leadership capabilities in the U.S.

Charles Sternberg, Assistant Editor 04.01.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Eloxx Pharmaceuticals Acquires Zikani Therapeutics

Combined company brings complementary Ribosomal RNA-targeted genetic therapy platforms together.

Kristin Brooks 04.01.21

Enteris BioPharma: Custom Solutions – From Bench to Market

CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

Clinical Trial Materials | Drug Development | Formulation Development

On-Demand Webinar: Accelerated Timelines for Clinical Supply Manufacture

Watch this on-demand webinar to gain a deeper understanding of the value of adaptive processes at this critical early stage of drug development.

GSK Supports Manufacture of Novavax’ COVID-19 Vaccine

GSK will provide fill and finish manufacturing capacity for up to 60 million doses at its Barnard Castle facility.

Tim Wright, Editor, Contract Pharma 03.31.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Ajinomoto, Bright Peak Enter Immunocytokines Research Pact

Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.

Kristin Brooks 03.30.21

Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer

CureVac, Celonic Enter COVID-19 Vax Mfg. Pact

Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.

Kristin Brooks 03.30.21

Biologics, Proteins, Vaccines | cGMP Manufacture

Advanced Analytics Advancing Development of Genetic Vaccines

Leveraging innovative advanced analytical technologies to ensure regulatory compliance in the development and production of novel vaccines.

Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 03.29.21

Drug Delivery | Extractables and Leachables

E&L Considerations for Customized Syringe Delivery Systems

Join James Scull, Ph.D., Scientific Director for Element Life Sciences, to gain a deeper understanding of E&L evaluations of custom drug delivery devices.

03.29.21